在晚期子宫癌中使用Endostar和化学放射治疗:比较疗效和预后
1Department of Radiotherapy III, Shaanxi Provincial Cancer Hospital No. 309 Yanta West Road, Yanta District, Xi'an 710061, Shaanxi, China.
American journal of translational research
|March 17, 2025
概括
结合化学放射治疗的Endostar可显著提高局部晚期宫癌 (LACC) 的治疗疗效和生存率,而不会增加不良影响. 这种组合治疗为LACC患者提供了更安全,更有效的策略.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 药理学 药理学是指药理学的学科.
背景情况:
- 局部晚期宫癌 (LACC) 需要有效的治疗策略.
- 传统的化学放射治疗是LACC的标准治疗方法.
- 研究新的治疗组合对于改善患者的治疗结果至关重要.
研究的目的:
- 为了评估Endostar与LACC的同步化疗放射治疗的疗效和安全性.
- 为了比较这种结合方法与传统的化学放射治疗.
- 评估对患者预后和生存率的影响.
主要方法:
- 对182名LACC患者的回顾性分析.
- 对照组 (传统化学放射治疗) 和组合组 (endostar + 化学放射治疗) 的比较.
- 使用考克斯回归和ROC分析评估治疗疗效,不良反应,瘤标志物,存活率和风险因素.
主要成果:
- 组合组显示出明显更高的客观缓解率 (74.47%对54.55%).
- 两组之间没有观察到副作用的显著差异.
- 组合组的治疗后瘤标志物水平 (SCC-Ag,CA125,CEA) 显著降低,1年和3年生存率更高.
- 结合化学放射治疗的Endostar被确定为3年死亡率的独立保护因素.
结论:
- 结合同步化疗和放射治疗的Endostar是一种安全有效的LACC治疗方法.
- 与单独使用化疗或放射治疗相比,这种组合显著改善了短期疗效和长期存活率.
- 这些发现支持内结合疗法作为LACC的优越治疗策略.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
199
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Comparing the Survival Analysis of Two or More Groups
113
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
113
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
